Disseminated intravascular coagulation immediately after trauma predicts a poor prognosis in severely injured patients.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 05 2021
Historique:
received: 02 02 2021
accepted: 04 05 2021
entrez: 27 5 2021
pubmed: 28 5 2021
medline: 30 10 2021
Statut: epublish

Résumé

Trauma patients die from massive bleeding due to disseminated intravascular coagulation (DIC) with a fibrinolytic phenotype in the early phase, which transforms to DIC with a thrombotic phenotype in the late phase of trauma, contributing to the development of multiple organ dysfunction syndrome (MODS) and a consequently poor outcome. This is a sub-analysis of a multicenter prospective descriptive cross-sectional study on DIC to evaluate the effect of a DIC diagnosis on the survival probability and predictive performance of DIC scores for massive transfusion, MODS, and hospital death in severely injured trauma patients. A DIC diagnosis on admission was associated with a lower survival probability (Log Rank P < 0.001), higher frequency of massive transfusion and MODS and a higher mortality rate than no such diagnosis. The DIC scores at 0 and 3 h significantly predicted massive transfusion, MODS, and hospital death. Markers of thrombin and plasmin generation and fibrinolysis inhibition also showed a good predictive ability for these three items. In conclusion, a DIC diagnosis on admission was associated with a low survival probability. DIC scores obtained immediately after trauma predicted a poor prognosis of severely injured trauma patients.

Identifiants

pubmed: 34040091
doi: 10.1038/s41598-021-90492-0
pii: 10.1038/s41598-021-90492-0
pmc: PMC8154895
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11031

Références

Crit Care. 2014 Apr 03;18(2):R61
pubmed: 24708802
Crit Care Med. 2006 Mar;34(3):625-31
pubmed: 16521260
J Thromb Haemost. 2019 Jun;17(6):852-862
pubmed: 30985957
F1000Res. 2017 Dec 18;6:2143
pubmed: 29399324
Haematologica. 1999 Mar;84(3):254-9
pubmed: 10189392
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Ann Surg. 2007 May;245(5):812-8
pubmed: 17457176
J Trauma. 2005 Mar;58(3):475-80; discussion 480-1
pubmed: 15761339
Crit Care Med. 2015 Jul;43(7):1429-38
pubmed: 25816119
J Thromb Haemost. 2020 Sep;18(9):2232-2244
pubmed: 32480432
PLoS One. 2020 Jan 24;15(1):e0228082
pubmed: 31978109
J Am Coll Surg. 2019 May;228(5):760-768.e1
pubmed: 30677527
Semin Thromb Hemost. 2016 Mar;42(2):155-65
pubmed: 26716498
Trauma Surg Acute Care Open. 2020 May 14;5(1):e000382
pubmed: 32432170
Thromb Haemost. 2002 Dec;88(6):943-9
pubmed: 12529743
J Trauma. 2009 Feb;66(2):346-52
pubmed: 19204506
Shock. 2018 Apr;49(4):420-428
pubmed: 28945676
J Trauma Acute Care Surg. 2013 May;74(5):1223-9; discussion 1229-30
pubmed: 23609271
Shock. 2008 Mar;29(3):334-41
pubmed: 18437714
Clin Appl Thromb Hemost. 2012 Jul;18(4):364-9
pubmed: 22275391
Ann Surg. 1999 Jan;229(1):121-7
pubmed: 9923809
Front Med (Lausanne). 2015 Apr 24;2:24
pubmed: 25964951
PLoS Med. 2017 Jul 17;14(7):e1002352
pubmed: 28715416
Thromb Res. 2019 Jul;179:11-14
pubmed: 31059996
Crit Care Med. 1999 Feb;27(2):427-30
pubmed: 10075072
Thromb Res. 2009 Nov;124(5):608-13
pubmed: 19660788
Am J Respir Crit Care Med. 2013 Jan 15;187(2):160-9
pubmed: 23220920
Crit Care Med. 1996 Jul;24(7):1125-8
pubmed: 8674323
J Trauma Acute Care Surg. 2012 Dec;73(6):1395-400
pubmed: 23064602
J Thromb Haemost. 2013 May;11(5):826-35
pubmed: 23522358
J Thromb Haemost. 2011 Jul;9 Suppl 1:182-8
pubmed: 21781254
Surgery. 2011 Feb;149(2):221-30
pubmed: 20655560
Crit Care Med. 2008 Jan;36(1):145-50
pubmed: 18090367
Crit Care Med. 1992 Jun;20(6):864-74
pubmed: 1597042
Semin Thromb Hemost. 2015 Feb;41(1):35-42
pubmed: 25590522
JAMA. 2001 Oct 10;286(14):1754-8
pubmed: 11594901
Crit Care. 2015 Feb 23;19:72
pubmed: 25886801
Nature. 2010 Mar 4;464(7285):104-7
pubmed: 20203610
Nat Rev Dis Primers. 2016 Jun 02;2:16037
pubmed: 27250996
J Thromb Haemost. 2020 Mar;18(3):740-747
pubmed: 32112533

Auteurs

Takeshi Wada (T)

Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan. twada1@med.hokudai.ac.jp.

Atsushi Shiraishi (A)

Emergency and Trauma Center, Kameda Medical Center, Kamogawa, Japan.

Satoshi Gando (S)

Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan.
Department of Acute and Critical Care Medicine, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.

Kazuma Yamakawa (K)

Department of Emergency Medicine, Osaka Medical College, Osaka, Japan.

Seitaro Fujishima (S)

Center for General Medicine Education, Keio University School of Medicine, Tokyo, Japan.

Daizoh Saitoh (D)

Division of Traumatology, Research Institute, National Defense Medical College, Saitama, Japan.

Shigeki Kushimoto (S)

Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Hiroshi Ogura (H)

Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Toshikazu Abe (T)

Department of Emergency and Critical Care Medicine, Tsukuba Memorial Hospital, Tsukuba, Japan.
Health Services Research and Development Center, University of Tsukuba, Tsukuba, Japan.

Toshihiko Mayumi (T)

Department of Emergency Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

Junichi Sasaki (J)

Department of Emergency and Critical Care Medicine, Keio University School of Medicine, Tokyo, Japan.

Joji Kotani (J)

Division of Disaster and Emergency Medicine, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Japan.

Naoshi Takeyama (N)

Advanced Critical Care Center, Aichi Medical University Hospital, Nagakute, Japan.

Ryosuke Tsuruta (R)

Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Ube, Japan.

Kiyotsugu Takuma (K)

Emergency and Critical Care Center, Kawasaki Municipal Hospital, Kawasaki, Japan.

Norio Yamashita (N)

Department of Emergency and Critical Care Medicine, School of Medicine, Kurume University, Kurume, Japan.

Shin-Ichiro Shiraishi (SI)

Department of Emergency and Critical Care Medicine, Aizu Chuo Hospital, Aizuwakamatsu, Japan.

Hiroto Ikeda (H)

Department of Emergency Medicine, Trauma and Resuscitation Center, Teikyo University School of Medicine, Tokyo, Japan.

Yasukazu Shiino (Y)

Department of Acute Medicine, Kawasaki Medical School, Kurashiki, Japan.

Takehiko Tarui (T)

Department of Trauma and Critical Care Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Taka-Aki Nakada (TA)

Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Toru Hifumi (T)

Department of Emergency and Critical Care Medicine, St. Luke's International Hospital, Tokyo, Japan.

Kohji Okamoto (K)

Department of Surgery, Center for Gastroenterology and Liver Disease, Kitakyushu City Yahata Hospital, Kitakyushu, Japan.

Yuichiro Sakamoto (Y)

Emergency and Critical Care Medicine, Saga University Hospital, Saga, Japan.

Akiyoshi Hagiwara (A)

Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.

Tomohiko Masuno (T)

Department of Emergency and Critical Care Medicine, Nippon Medical School, Tokyo, Japan.

Masashi Ueyama (M)

Department of Trauma, Critical Care Medicine, and Burn Center, Japan; Community Healthcare Organization, Chukyo Hospital, Nagoya, Japan.

Satoshi Fujimi (S)

Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.

Yutaka Umemura (Y)

Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Yasuhiro Otomo (Y)

Trauma and Acute Critical Care Center, Medical Hospital, Tokyo Medical and Dental University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH